Wednesday, February 27, 2008  Medscape--Brought to you by
Lexapro  It's sad to watch a company selling its soul. Medscape
used to be a source of reasonably trustworthy medical
information with a few drug company ads thrown in to help pay
the bills. Gradually, however, the promise of ever increasing
riches became too alluring. It began selling disease-specific
"resource centers" to the highest bidder (see my prior post
here), earning millions from companies keen to control which
articles are fed to doctors believing they are receiving medical
education. At least these resource centers have a pretense of
legitimacy, and if you dig around you can usually find something
of value.  How things have changed. Today when I opened my
email's inbox I received an email from Medscape. On the subject
line: "Reasons to Choose Lexapro First." Eloquent in its
simplicity. When I opened the email, I received nothing more
than an advertisement for Lexapro (pasted above).  Yes, it
appears that Medscape has found a new buyer for i